Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)

Clinical trial NCT01568021 · COMPLETED

Trial details

NCT number: NCT01568021
Sponsor: Allergan
Status: COMPLETED
Study type: OBSERVATIONAL

Retinal Vein Occlusion Macular Edema

Start date: 2011-10-01
Primary completion: 2013-11-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.